How much is Skyhawk Therapeutics worth in 2026?

Skyhawk Therapeutics has a current valuation of N/A based on their Later Stage VC (Series B) round and secondary market data.

How much funding has Skyhawk Therapeutics raised?

Skyhawk Therapeutics has raised N/A in total funding across 1 funding rounds.

Skyhawk Therapeutics

Drug Discovery

Skyhawk Therapeutics valuation and funding history | Last updated: June 30, 2021 | 1 funding rounds

Current Valuation

N/A

As of June 30, 2021

Total Funding Raised

N/A

Across 1 round

Last Round

Later Stage VC (Series B)

$134.0M

Last Funding

Jun 2021

Funding date

Capital Efficiency

N/A

Valuation / Funding

Funding History & Valuation Timeline

Complete history of all funding rounds and valuation milestones

Date	Round	Amount	Post-Valuation	Growth
June 30, 2021	Later Stage VC (Series B)	$134.0M	N/A	-

Valuation Analysis

Current Valuation Metrics

Skyhawk Therapeutics is currently valued at N/A as of June 30, 2021.

Track Skyhawk Therapeutics Valuation Updates

Get notified when Skyhawk Therapeutics raises new funding or valuation changes

Explore More Data

Detailed analysis for Skyhawk Therapeutics

Secondary Market Price

Real-time pricing data and trends

Valuation Tracker

Historical valuation changes

Funding History

Complete funding round timeline

Secondary Price History

Historical transaction data

All Investors

Complete list of all investors

View 5 companies free

Create a free account to unlock Skyhawk Therapeutics's valuation history, funding rounds, and growth metrics.

No credit card required

What is Skyhawk Therapeutics Worth in 2026?

Skyhawk Therapeutics is a leading private company in the Drug Discovery sector. Track Skyhawk Therapeutics's valuation history, funding timeline, and implied market value from secondary transactions on Premier Alternatives.

How Skyhawk Therapeutics Valuation is Determined

Private company valuations like Skyhawk Therapeutics's are determined through primary funding rounds led by venture capital firms, private equity investors, and strategic partners. The valuation reflects factors including revenue growth, market opportunity, competitive positioning, and investor sentiment.